Quick Takeaways
- Dicerna Pharmaceuticals Inc has 17 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are not currently available.
Insider Transactions Reported by 17 Insiders of Dicerna Pharmaceuticals Inc
- Location
- Lexington, MA
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 05 May 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Dicerna Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Anna Protopapas | Director | $127,487 | Mixed | 03 Jun 2021 | ||
| Regina M. Paglia | Chief Human Resources Officer | $77,533 | Mixed | 06 Jul 2021 | ||
| Adam Koppel | Director | Mixed | 28 Dec 2021 | |||
| Marc D. Kozin | Director | Mixed | 28 Dec 2021 | |||
| Douglas Fambrough | Chief Executive Officer, Director | Mixed | 28 Dec 2021 | |||
| Cynthia Smith | Director | Mixed | 28 Dec 2021 | |||
| Stephen K. Doberstein | Director | Mixed | 28 Dec 2021 | |||
| Martin I. Freed | Director | Mixed | 28 Dec 2021 | |||
| Robert D. Ciappenelli | Chief Strategy Officer | Mixed | 28 Dec 2021 | |||
| Douglas W. Pagan | Chief Financial Officer | Mixed | 28 Dec 2021 | |||
| James B. Weissman | Chief Operating Officer & EVP | Mixed | 28 Dec 2021 | |||
| Stephen J. Hoffman | Director | Mixed | 28 Dec 2021 | |||
| J. Kevin Buchi | Director | Mixed | 28 Dec 2021 | |||
| Bob D. Brown | Chief Scientific Ofr., EVP R&D | Mixed | 28 Dec 2021 | |||
| Shreeram Aradhye | EVP & Chief Medical Officer | Mixed | 28 Dec 2021 | |||
| Ling Zeng | Chief Legal Officer & Sec'y | Mixed | 28 Dec 2021 | |||
| Patrick M. Gray | Director | Mixed | 28 Dec 2021 |
Top shareholders of Dicerna Pharmaceuticals Inc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Anna Protopapas |
3/4/5
|
Director |
—
class O/S missing
|
3,333
|
$127,487 | — | 03 Jun 2021 | |
| Regina M. Paglia |
3/4/5
|
Chief Human Resources Officer |
—
mixed-class rows
|
63,236
mixed-class rows
|
$77,533 | — | 06 Jul 2021 |
Recent Insider Transactions by Companies or Individuals for Dicerna Pharmaceuticals Inc
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* An asterisk sign (*) next to the price indicates that the price is likely invalid.